Home
About Us
About Us
Industry Recognition
Experts
Milestones
Platforms
SoInAb™
SoInNuc™
SoInZyme™
SoInCell™
SoInMat™
Solutions
Metabolic Disease Therapeutics
Musculoskeletal Regeneration
Regenerative Biomaterials
Smart Health Management
Ecosystem
Ecosystem
Technologies
Products
News
Contact
Contact
Careers
Message
中文
Position：
Home
>>
About Us
>>
Milestones
>>
2026
2026
All
The SoInAb™ antibody platform reached PCC, expanding the antibody drug candidate pool.
2026-07-22
More >>
The SoInNuc™ Intelligent Nucleic Acid Drug Development Platform was launched.
2026-07-22
More >>
The SoInZyme™ Enzyme Engineering Platform was launched.
2026-07-22
More >>
Strategic partnerships were established with multiple pharmaceutical companies to advance the translational deployment of small nucleic acid and enzyme optimization technologies.
2026-07-22
More >>
The tendon stem cell drug candidate completed national filing.
2026-07-22
More >>
The Longevity Clinic was launched to explore an integrated "R&D–Production–Application" model.
2026-07-27
More >>
National High-Tech Enterprise status is under review.
2026-07-27
More >>
Class II medical device approval was received.
2026-07-27
More >>
1
